These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Coagulation disorders in septic shock. Thijs LG; de Boer JP; de Groot MC; Hack CE Intensive Care Med; 1993; 19 Suppl 1():S8-15. PubMed ID: 8227738 [TBL] [Abstract][Full Text] [Related]
43. Some recent advances in the study of hemostasis. Ratnoff OD Circ Res; 1974 Jul; 35(1):1-14. PubMed ID: 4601719 [No Abstract] [Full Text] [Related]
44. The hemostatic mechanism and its defects. Macfarlane RG Int Rev Exp Pathol; 1968; 6():55-133. PubMed ID: 4884086 [No Abstract] [Full Text] [Related]
45. [Severe sepsis and septic shock: crossroad of inflammation and coagulation]. Torrabadella de Reynoso P; Salgado Remigio A Med Clin (Barc); 2001 Jun; 116(20):782-8. PubMed ID: 11440685 [No Abstract] [Full Text] [Related]
46. Blood coagulation and fibrinolysis. Heimburger N; Trobisch H Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468 [No Abstract] [Full Text] [Related]
47. The syndrome of intravascular coagulation. Rodriguez-Erdmann F Postgrad Med; 1974 May; 55(5):91-8. PubMed ID: 4824725 [No Abstract] [Full Text] [Related]
48. [Acute defibrination without fibrinolysis associated with postabortum septicemia. Clinical and biologic study]. Dérot M; Samama M; Leclercq A; Capelle C; Cohen L; Robert M Presse Med (1893); 1968 Jun; 76(27):1351-2. PubMed ID: 5303919 [No Abstract] [Full Text] [Related]
49. [Relation between the hemostatic process and thrombosis. A clinical problem]. Ponari O; Dettori AG Recenti Prog Med; 1968 Sep; 45(3):259-82. PubMed ID: 4916345 [No Abstract] [Full Text] [Related]
50. Activated leukocytes and the hemostatic system. Lüscher EF Rev Infect Dis; 1987; 9 Suppl 5():S546-52. PubMed ID: 3317750 [TBL] [Abstract][Full Text] [Related]
51. [Physiology of hemostasis. II. Fibrinolysis]. Sultan Y; Caen J; Allain JP; Meyer D Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805 [No Abstract] [Full Text] [Related]
52. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R). Bouma BN; Meijers JC Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415 [TBL] [Abstract][Full Text] [Related]
53. [Modern data on the chemistry and physiology of fibrinogen]. Andreenko GV Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801 [No Abstract] [Full Text] [Related]